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Abstract
Background: Dengue fever (DF) outbreaks present regionally specific epidemiological and clinical characteristics. In
certain medium-sized cities (100 000–250 000 inhabitants) of São Paulo State, Brazil, and after reaching an incidence
of 150 cases/100 000 inhabitants (“epidemiological threshold”), clinical diagnosis indicated dengue virus (DENV)
infection. During this period, other seasonally infectious diseases with symptoms and physical signs mimicking DF
can simultaneously occur, with the consequential overcrowding of health care facilities as the principal drawbacks.
Confirmation of clinical diagnosis of DF with serological tests may help in avoiding faulty diagnosis in patients, who
might later undergo dengue hemorrhagic fever (DHF) and the dengue-shock syndrome (DSS). Furthermore,
demographic and hematological profiles of patients are useful in detecting specific early characteristics associated
to DF, DHF and DSS.
Methods: From March to June, 2007, 456 patients from Marilia in northwest São Paulo State who had only been
diagnosed for DF by clinical criteria, underwent serologic testing for non-structural 1 (NS1) DENV antigens.
Individual results were used in comparative analysis according to demographic (gender, age) and hematological
(leukocyte and platelet counts, percentage of atypical lymphocytes) profiles. Temporal patterns were evaluated by
subdividing data according to time of initial attendance, using recorded variables as predictors of DENV infection in
logistic regression models and ROC curves.
Results: Serologic DENV detection was positive in 70.6 % of the patients. Lower leukocyte and platelet counts
were the most important factors in predicting DENV infection (respective medians DENV + = 3 715 cells/ml
and DENV- = 6 760 cells/ml, and DENV + = 134 896 cells/ml and DENV- = 223 872 cells/ml). Furthermore, all
demographic and hematological profiles presented a conservative temporal pattern throughout this long-lasting
outbreak.
Conclusions: As consistency throughout the epidemic facilitated defining the conservation pattern throughout the
early stages, this was useful for improving management during the remaining period.
Keywords: Clinical diagnosis, Demographic profile, Dengue fever, Dengue- outbreak pattern, Epidemiological
threshold, Hematological profile
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Background
The dengue virus of the genus Flavivirus (family
Flaviviridae) is represented by four serotypes (DENV1
to 4), which are transmitted to humans by infected
female Aedes aegypti and A. albopictus mosquitoes,
widely distributed throughout tropical and subtropical
regions [1]. According to the World Health Organization
[2], 40 % of the population world-wide run the risk of
DENV infection, with an estimated 50 to 100 million cases
annually and around 20 000 fatalities.
Disease manifestation in DENV infected individuals
ranges from absence or unspecified to classical dengue
fever (DF), characterized by fever associated to muscle,
joint and retro-orbital pain, photophobia and red body-
rash. The most severe and lethal forms of the disease are
characterized by increased vascular permeability, plasma
leakage, thrombocytopenia and hemorrhagic manifesta-
tions [3, 4]. Risk factors, which vary in populations
world-wide [5], include sequential DENV infection with
a different virus serotype, diversity in genetic character-
istics of both virus and host, vector dispersion and
adaptability, and sequential virus serotype infection.
In medium-sized cities (100 000–300 000 inhabitants),
DF outbreaks typically last for four to six months during
the hot and rainy seasons, with specific epidemiological
and clinical characteristics in space and time [6, 7]. In
the New World, the spread of DENV has increased five-
fold over the latter decades, with outbreaks occurring
every three to five years through co-circulation of the
four serotypes of DENV, with total severe dengue case
fatality reaching 1.2 % [8]. Within this scenario and since
2000, Brazil has accounted for more than 70 % of DENV
cases in the Americas, with a period of outstanding
A. aegypti dispersion [9]. By mid-2007 and in all the
dengue epidemics, adults from urban and surrounding
locations were the most affected. However, in some
regions and from the second half of 2007, there has
been a change in this pattern, with a significant in-
crease in severe dengue hemorrhagic cases in under-
15-year-old children in the northeast and Rio de
Janeiro State [10]. Nonetheless, the adult population
continues to be the most affected. Hence, there is the
need for regional studies to facilitate early recognition
of any modification in the DENV epidemiological pattern,
to thus improve control and treatment procedures.
In São Paulo State, concentration of DENV cases in
urban centers has changed, with an increased incidence
in small and medium-sized towns. In 2007, 52 % of the
cases were reported in towns with less than 100 000
inhabitants, with 16 % occurrence in counties with pop-
ulations ranging between 100 000 and 500 000 (Ministry
of Health, 2007).
Marilia, a town in the west of São Paulo State, 450 km
from the capital, with 216 745 inhabitants (IBGE 2010)
and a large population flow due to economic relevance,
represents a model for investigating DENV epidemiology
in medium-sized towns state-wide. In the 2007 Marilia-
outbreak, which reached 550 cases/100 000 inhabitants,
in the first instance, only around 300 cases were con-
firmed through serological analysis. Subsequently, all
suspected cases were required to be notified and submit-
ted to hematological check-ups for detection and poster-
ior treatment of severe hemorrhagic cases, whence the
consequential overcrowding of health facilities.
During outbreaks, the use of such “epidemiological
threshold” procedures in accordance with clinical criteria
for DENV diagnosis, but without serological confirmation,
imposes another significant problem; the co-occurrence of
various seasonal infectious diseases with similar symp-
toms. These include other arboviruses, such as the flavivi-
rus Saint Louis Encephalitis [11], Chikungunya fever
[12, 13], Zika fever [14], leptospirosis [15, 16], visceral
leishmaniasis [17], and malaria [18].
Certain demographic characteristics, such as the age
of patients diagnosed with DENV, can be associated
to distinct epidemiological patterns of DENV trans-
mission [19]. Furthermore, early identification of the
hematological profile during the fever period can dif-
ferentiate DENV from other infectious diseases [20].
Thus, the aim hereby was to assess the demographic
and hematological profiles of patients under treatment
at the Marilia Hemocenter during the 2007 DF out-
break, and diagnosed by clinical criteria according to
DF epidemiological threshold procedures. DENV infec-
tion in such individuals was investigated a posteriori
(retrospectively) by way of serological testing.
Methods
Patients and laboratory analysis
When, during the 2007 outbreak, serologically con-
firmed dengue incidence reached the epidemiological
threshold of 150/100 000 inhabitants in Marilia, 754 pa-
tients were diagnosed for dengue only by clinical means.
They were attended to at the Marilia Hemocenter from
March, 7 to June, 4. From the onset, they underwent a
posteriori investigation to assess the serological status
(DENV presence/absence), and demographic (gender
and age) and hematological (leukocyte and platelet
counts, and percentage of atypical lymphocytes) profiles
of each. Only individuals with complete records (gender,
age, leukocyte and platelet counts, and percentage of
atypical lymphocytes) came under analysis. Hematocrit
results, also monitored from the beginning, showed less
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than 6 % of investigated patients (26 out of 456) pre-
sented values above standard levels (42 % for under-12-
year-old children, 44 % for adult women and 50 % for
adult men) [21]. Percentages of red blood cells among
under-12-year-olds (n = 34) ranged from 27.5 to 45.5
(median - 38.3; first and third quartiles 35.3 and 41.3, re-
spectively); among women (n = 226) from 32.2 to 49.6
(median - 40.0; first and third quartiles 37.8 and 42.0, re-
spectively); and among men (n = 196) from 29.1 to 49.9
(median - 44.1, first and third quartiles 41.5 and 45.8
respectively). However, since according to clinical and
laboratory follow up, no patient presented hemoconcen-
tration, these data were not included for further analysis.
Blood-samples were collected in EDTA tubes from
each patient for cell counting. The remaining material
was centrifuged for plasma separation, and after fro-
zen at −20 °C. Atypical lymphocytes were investigated
by blood smear microscopic examination after Giemsa
staining. Plasma samples underwent DENV serological
diagnosis by enzyme linked immunosorbent assay de-
tection of non-structural 1 (NS1) antigen, using the
“Focus Diagnostics’ Dengue NS1 Antigen DxSelect™
Assay”, according to manufacturers’ instructions. Research
protocol was approved by the Ethics Committee on
Human Research of the Marilia Medical School (number
069/03).
Statistical analysis
Among the 456 patients with complete records, and
based on serological outcomes (positive cases = DENV+;
negative cases = DENV-) two groups were described
through distribution by gender (labeled as SEX, with
males coded as 1, females as 0), age in years (AGE),
leukocyte and platelet counts (respectively, LEU and
PLA, both in Log10 cells/ml), and percentage of atypical
lymphocytes (AL%). On the first day of attendance at
the Hemocenter, DAY, counted from the start of the 89-
days-interval, was also used in the survey. Within each
group, these variables were evaluated separately by de-
scriptive statistics. The groups were compared using the
X2 test for SEX (in a 2×2 contingency table), and the
Mann–Whitney for the remaining variables. Bivariate
analysis was by Spearman rank correlations. In a con-
trary approach, the six variables were evaluated as inde-
pendent explanatory factors, and according to their
probability to predict DENV serological outcome. Logis-
tic regression models were used to detect significant ef-
fects of each factor on the dichotomic response variable
(DENV+ as 1, DENV- as 0). An additive model including
all the six factors was also built. Parameters from the
first set of models (explanatory factors used individually)
described the relationship between each factor and the
response variable by means of logit functions. Analysis
was with the Pezzulo (2012) free online device for
calculating logistic regression. Additional estimates of
confidence intervals were obtained with Statistica 8.0
(Statsoft Co) software. Akaike Information Criteria (AIC
values) were computed in an R software package. For all
the variables except SEX, sigmoidal curves relating
values to the response variable were plotted. Receiver
operating characteristic (ROC) curves were plotted for
all the factors except SEX. Confidence intervals for both
specificity and sensibility were compiled with the R
package pROC [22], as was the case of comparison
among areas below the curves (AUC).
We evaluated how the different subsets of patients ob-
tained from distinct periods of first attendance at the
Marilia Hemocenter could generate particular individual
explanations of serological outcome with the selected
factors. Data were divided into four subsets, each
comprised of an equal number of individuals (s1 to s4;
N = 114 in all), with the first and the last quarter of pa-
tients to arrive at the Marilia Hemocenter being placed
accordingly in the subsets. Each of the four was treated
as an entire set of data to so build up new logistic re-
gression and ROC curves. Comparison was between
these subsets and the entire sample. Unless otherwise
explicitly stated, P-values were considered following
Bonferroni correction based on the number of similar
tests.
Results
As an indication of the absence of sampling bias, data
from the discarded group of patients with incomplete
records (Nout = 330) did not differ significantly from
those of the group of patients included in the analysis
(Nin = 456), when considering (a) sex (2×2 contin-
gency table: X2 = 35.4; P = 0.3775; Nout = 330), (b) age
(Mann–Whitney U = 28 940; P = 0.1907; Nout = 137),
(c) day of the first attendance at the Hemocenter
(Mann–Whitney U = 73 110; P = 0.4982; Nout = 330),
or (d) representativeness of original location (number of
patients in both groups from 23 Marilia districts compared
by Spearman rank correlation: rS = 0.826; P < 0.0001;
Nout = 82).
A summary of variables and univariate comparison be-
tween the two groups of serological outcome appears in
Table 1. Among the 456 patients evaluated, 322 (70.6 %)
were serum positive (DENV+). In the latter, 48.1 % were
males with median age of 35 years. The median time
of the first attendance at the Marilia Hemocenter
since sampling started was 41 days. Among serum-
negative patients (DENV-), males comprised 42.6 %
with a median age of 29 years. The Median time from
first attendance was 38.5 days. For the three variables
SEX, AGE, and DAY, differences among groups were
insignificant. Groups differed significantly as regards
hematological conditions. Leukocyte and platelet counts
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were lower in positive patients (leukocyte medians:
DENV + = 3 715 cells/ml and DENV- = 6 760 cells/ml;
platelet medians: DENV + = 134 896 cells/ml and
DENV- = 223 872 cells/ml) Transformed logarithmic
values are presented in Table 1. Percentages of atyp-
ical lymphocytes were lower among negative patients
(medians: DENV + = 4 % and DENV- = 1 %). In both
groups, hematological variables were mutually strongly
correlated. Whereas in leukocyte and platelet counts this
was positive, in atypical lymphocytes it was negative
(Table 2). With the exception of DAY and platelet counts
in DENV-patients, there were no correlations between the
variables SEX, DAY and AGE or any other variable in any
group.
Logistic regression showed significant LEU and PLA
usefulness in foreseeing DENV serological outcome, as
reinforced by models with individually presented factors
for the entire dataset (Table 3). As already mentioned,
these two variables were strongly correlated in both
groups (DENV+ and DENV-; Table 2). The contribution
of each factor (except SEX) as DENV-infection predic-
tors was presented in sigmoidal curves (Fig. 1). When
using the entire dataset, SEX, DAY and AGE proved to
be non-significant factors (in the latter two, only proven
after Bonferroni correction for critical P) in their re-
spective and exclusive models. Among all the subsets,
LEU and PLA alone remained individually significant
factors. AL% (s1 and s4) and DAY (s3) also appeared
punctually in the subsets as significant individual
factors.
In the all-inclusive additive logistic regression model
for evaluating the contribution of the six DENV-
infection explanatory factors (Table 4), only LEU and
PLA presented significant effects in the entire dataset.
LEU presented significant results in all the subsets (only
this in s1, and with DAY in s3 and AL% in s4), except in
s2. In this, and as AGE and PLA had been discarded by
Bonferroni correction, no factor could be considered sig-
nificant. In no subset did SEX, AGE and PLA appear as
significant factors. A model using only LEU and PLA ad-
ditively for the entire dataset resulted in an AIC value
(409.4) lower than those of both “individualized” models
(423.6 for LEU and 457.2 for PLA; Table 3). This two-
factor model was slightly better than the “full” additive
Table 1 Demographic and hematological status of DENV+ and
DENV- patients in the 2007 Marilia outbreak
Variable DENV+ DENV- Test P
SEX % males 48.1 42.5 1.19 0.2748
DAY Mean 42.25 37.84 19,050 0.0485
Standard deviation 19.906 20.396
Median 41 38.5
Range (0–86) (0–86)
AGE Mean 37.08 32.55 18,410 0.0137
Standard deviation 18.558 19.774
Median 35 29
Range (0–85) (1–78)
LEU Mean 3.57 3.83 7654 <0.0001
Standard deviation 0.205 0.197
Median 3.56 3.83
Range (2.95–4.30) (3.28–4.39)
PLA Mean 5.12 5.33 8830 <0.0001
Standard deviation 0.214 0.180
Median 5.13 5.35
Range (4.00–5.69) (4.64–5.87)
AL% Mean 6.52 2.50 13,160 <0.0001
Standard deviation 6.791 3545
Median 4 1
Range (0–39) (0–20)
Demographic and hematological status of patients from two groups based on
serological outcomes in Dengue virus testing (DENV+ N = 322, DENV- N = 134).
Gender (SEX), age (AGE, in years), leukocyte and platelet counts (respectively
LEU and PLA, both in Log10 cells/ml), percentage of atypical lymphocytes (AL%)
and day of the first attendance at the Marilia Hemocenter (DAY, counted from
March 07, 2007, when sampling started) were recorded for 456 patients. All test
values are Mann–Whitney U comparisons among groups, except for SEX
(X2 applied to a two-way contingency table). P-values lower than critical
(Pc = 0.05/6 = 0.0083, considering six contrasts in a Bonferroni correction) were
shown in bold
Table 2 Spearman rank correlation among demographic and
hematological variables for DENV+ and DENV- patients
DENV+ DENV-
X x Y Rs P Rs P
SEX x DAY −0.023 0.6847 −0.078 0.3696
SEX x AGE −0.093 0.0971 −0.017 0.8421
SEX x LEU 0.012 0.8287 −0.142 0.1020
SEX x PLA −0.083 0.1379 −0.185 0.0326
SEX x AL% 0.026 0.6422 0.112 0.1985
DAY x AGE 0.733 0.0191 0.202 0.1110
DAY x LEU −0.016 0.7739 −0.171 0.0488
DAY x PLA 0.062 0.2679 −0.299 0.0004
DAY x AL% 0.139 0.0124 0.104 0.2303
AGE x LEU 0.094 0.0915 −0.061 0.4872
AGE x PLA 0.030 0.5974 −0.172 0.0475
AGE x AL% −0.038 0.4954 0.045 0.6053
LEU x PLA 0.496 <0.0001 0.336 0.0001
LEU x AL% −0.318 <0.0001 −0.376 <0.0001
PLA x AL% −0.482 <0.0001 −0.274 0.0014
Spearman rank correlation (RS, and their respective P-values) among
demographic and hematological variables in two groups of patients
(DENV+ N = 322, DENV- N = 134). Figures lower than critical P were in bold.
For 15 correlation tests in each group of patients, critical P = 0.05/15 = 0.0033.
Variable codes as in Table 1
dos Santos Carmo et al. Infectious Diseases of Poverty  (2016) 5:84 Page 4 of 11
model (AIC = 412.1) with all the six explanatory vari-
ables (Table 4).
According to both sensitivity and specificity, the fac-
tors AGE and DAY differed slightly from chance in
DENV discrimination: their ROC curves appear near the
graph diagonal (Fig. 2, Table 5). LEU and PLA, in this
order, were considered the best factors by simultan-
eously reaching the highest scores of true positives and
true negatives, as indicated by high AUC values (Fig. 2,
Table 5). The AL% was placed intermediately between
the two groups of variables (Fig. 2, Table 5). Except for
s3 in DAY, ROC curves computed for each factor of the
subsets were not statistically different from those com-
piled for the entire dataset (Table 6).
Discussion
Clinical criteria for post-epidemiological threshold phase
DF diagnosis have been largely employed in developing
countries, due to the technical and economic difficulties
in carrying out specific tests to confirm DENV infection
during outbreaks [23]. In these cases, blood-cell counts
of patients with DF symptoms are the procedure in
healthcare institutions, as a way of monitoring disease
evolution with the purpose of preventing and treating
the severe hemorrhagic form [24, 25]. Potentially, clin-
ical signs and the hematological profile of patients with
acute DENV infection can vary individually and region-
ally, due to epidemiological characteristics, such as the
presence of other seasonal infectious diseases, host and
virus genetic background, and previous virus circulation,
thereby making the use of only clinical criteria for diag-
nosis questionable [26]. In order to investigate the effect-
iveness of such criteria applied to febrile patients at the
Marilia Hemocenter during the 2007 outbreak, demo-
graphic and hematological status were assessed by apply-
ing a posteriori NS1-based DENV serological outcome
data.
Through presenting high sensitivity and specificity in
studies carried out in Brazil, NS1 antigen detection has
Table 3 Logistic regression models of demographic and
hematological factors as individual predictors of DENV infection
Dataset
Factors Statistics All s1 s2 s3 s4
Sex βo 0.774 0.392 1.276 0.928 0.649
β1 0.226 0.160 −0.288 0.325 0.660
OR 1.254 1.173 0.750 1.384 1.934
CL- 0.8352 0.5494 0.3175 0.5899 0.8172
CL+ 1.8823 2.5068 1.7716 3.2458 4.5777
P 0.2752 0.6794 0.5119 0.4553 0.1335
AIC 551.1 155.9 130.7 132.7 138.9
Day βo 0.435 0.312 2.048 −7.409 −1.499
β1 0.011 0.010 −0.027 0.178 0.036
OR 1.011 1.010 0.973 1.194 1.037
CL- 1.0009 0.9635 0.8820 1.0682 0.9876
CL+ 1.0214 1.0593 1.0737 1.3350 1.0891
P 0.0334 0.6728 0.5868 0.0018 0.1443
AIC 547.7 155.9 130.8 122.2 138.9
Age βo 0.427 0.033 0.292 0.615 0.879
β1 0.013 0.013 0.025 0.013 0.001
OR 1.013 1.013 1.025 1.014 1.001
CL- 1.0020 0.9934 0.9999 0.9896 0.9789
CL+ 1.0242 1.0331 1.0503 1.0379 1.0226
P 0.0210 0.1948 0.0510 0.2717 0.9628
AIC 546.8 154.3 126.9 132.1 141.2
LEU βo 24.173 32.162 18.422 20.852 25.583
β1 −6.3036 −8.4818 −4.6950 −5.3871 −6.7062
OR 0.002 0.001 0.009 0.005 0.001
CL- 0.0005 0.0000 0.0009 0.0004 0.0001
CL+ 0.0069 0.0048 0.0972 0.0594 0.0206
P <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
AIC 440.6 99.9 111.3 110.7 107.4
PLA βo 31.916 43.426 34.360 30.579 19.594
β1 −5.931 −8.143 −6.377 −5.646 −3.586
OR 0.003 0.001 0.002 0.003 0.028
CL- 0.0007 0.0001 0.0001 0.0002 0.0027
CL+ 0.0108 0.0068 0.0359 0.0705 0.2855
P <0.0001 <0.0001 <0.0001 0.0002 0.0026
AIC 464.6 109.8 106.7 115.1 130.3
AL% βo 0.192 −0.287 0.547 0.672 −0.242
β1 0.169 0.209 0.207 0.077 0.251
OR 1.184 1.233 1.230 1.080 1.285
CL- 1.1190 1.0950 1.0480 0.9891 1.1274
Table 3 Logistic regression models of demographic and
hematological factors as individual predictors of DENV infection
(Continued)
CL+ 1.2538 1.3875 1.4439 1.1793 1.4654
P <0.0001 0.0005 0.0113 0.0860 0.0002
AIC 511.8 136.1 118.9 129.8 118.1
Logistic regression models to evaluate the individual contribution of
demographic and hematological factors to DENV incidence using different
datasets (ALL = entire data; subsets s1 to s4 ordered by day of the first
attendance at the Marilia Hemocenter; see text). βo = intercept, β1 = slope,
OR odds ratio, and CL 95 % confidence limits. Figures lower than critical P
were in bold. Considering six models (one for each factor) with each
dataset, critical P = 0.05/6 = 0.0083. AIC indicate model fit (comparable
both between subsets and factors for subsets s1 to s4; comparable
between factors for ALL). Variable codes as in Table 1
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proved to be an important tool in early DF diagnosis
[27–30]. The kit employed in this investigation has an
expected Positive Percent Agreement (PPA) of 88.2 %
(95 % Confidence Interval: 73.4–95.3 %) and a Negative
Percent Agreement (NPA) of 100 % (95%CI: 93.2–
100.0 %) (manufacturer’s information). Accordingly, clin-
ical criteria success was confirmed in 70.6 % of the cases
reported. The remainder (29.4 %) was comprised of sam-
ples with a false DENV outcome or which corresponded
to other infectious diseases. In order to increase the
accuracy of DENV NS1 serological diagnosis, the detec-
tion of IgM/IgG DENV NS1 antibodies is recommended
[31, 32]. However it was impossible to do so in the
present study. Furthermore, serological tests to check
the presence of the different infectious agents were
omitted here.
Even though indicator efficiency of hematological
changes during progression in distinguishing DENV
from other infectious diseases is controversial, it remains
essential in the clinical management of DF and severe
hemorrhagic dengue [25, 33]. Leukocyte and platelet
counts below 3 760 cell/ml and 100 000 cells/ml,
respectively, and the presence of atypical lymphocytes,
are commonly found in classical and severe cases of DF
[20, 34, 35]. Our data showed a strongly significant asso-
ciation of decreased leukocyte and platelet counts in
DENV+ patients. ROC curves reinforced LEU and PLA
as the best factors for predicting serological DENV out-
comes (Fig. 1).
Biochemical liver damage markers, such as aspartate
aminotransferase (AST), and serum glutamic oxaloacetic
transaminase (SGOT), as well as alanine aminotransferase
Fig. 1 Sigmoidal curves showing individual contribution of demographic and hematological factors as independent predictors of DENV infection,
based on parameters of logistic regression in Table 2. Horizontal bars represent the entire dataset (with associated 95 % confidence intervals).
Subsets (see text) are s1 = squares, s2 = diamonds, s3 = triangles, s4 = circles. Variable codes as in Table 1
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(ALT) and serum glutamic pyruvic transaminase
(SGPT) serum levels, are used to evaluate dengue dis-
ease severity [2]. However, in our health system these
parameters are absent from the normal hematological
exam routine, and thus could not be included in the
study.
Data of the demographic status of a population in-
volved in a DENV outbreak facilitates characterization
of the epidemiological pattern of virus transmission,
thereby contributing towards prevention and manage-
ment. In Asia, where the number of severe hemorrhagic
dengue cases is the highest in the world, with a fatality
rate of 3.5 %, prevalence is higher in children under-
15 [36]. In the 2007 Marilia DENV outbreak, the
adult population was mostly affected by DF, with only
five cases of the non-lethal hemorrhagic form of the
disease (0.4 %). No differences in gender or age were
found among DENV+ and DENV- patients. This
DENV transmission pattern is the most common in
the Americas [9].
In the different regions of Brazil, the time span of
DF outbreaks after the establishment of an epidemio-
logical threshold, is long-lasting, and can continue
throughout the hot rainy season. In São Paulo State it
can last for four to six months [37]. During this
period, health care facilities are overcrowded and
there is confusion in diagnosis with seasonal diseases.
Moreover, and depending on the course of infection,
it is possible that hematologic changes, so commonly
associated with the more severe DENV diseases are
not very evident in initial data. Thus, in order to
further adapt monitoring of the disease, all patients sus-
pected of DENV infection are assayed for hematological
changes [38]. By taking into consideration the re-
gional demographic and hematological profiles of DF
and its more severe hemorrhagic form [39, 40], the
early definition of these characteristics can improve
management efficiency. Thus, in order to guarantee
maintenance of parameters throughout the 2007 Marilia
outbreak, the patients were divided into four temporally
consecutive subsets for comparative analysis. The results
indicated temporal homogeneity in demographic and
hematological profiles, especially brought into evidence by
logistic regression and ROC curves (Table 3 and Fig. 2).
This showed LEU and PLA |to be independent factors as-
sociated to DENV serological positive diagnosis during the
whole period.
There was also a statistically significant association of
hematological variables in all DENV serological positive
samples (Table 5), compatible with DENV infection la-
boratory findings [37]. However, certain differences were
found by additive logistic regression analysis, when com-
paring the entire dataset and subsets s1 to s4 (Tables 4
and 6). The most significant difference occurred in sub-
set s3, which presented high correlations with DENV
positive serological diagnosis. This difference could be
attributed to specific unidentified features related to
sampling during the period, since this was the only
Table 4 All inclusive, additive logistic regression models of
demographic and hematological factors as predictors of DENV
infection
Dataset
Statistics ALL s1 s2 s3 s4
AIC 412.1 97.5 107.1 103.4 98.1
Factors βo 30.194 54.258 30.300 31.291 15.871
Sex β1 −0.007 −1.006 0.1092 0.3120 0.7480
OR 0.993 0.366 1.115 1.366 2.113
CL- 0.6035 0.1079 0.3908 0.4545 0.6700
CL+ 1.6342 1.2385 3.1827 4.1066 6.6626
P 0.9784 0.1060 0.8383 0.5785 0.2018
Day β1 0.002 −0.050 −0.007 0.197 0.073
OR 1.002 0.951 0.993 1.218 1.076
CL- 0.9900 0.8872 0.8854 1.0630 1.0049
CL+ 1.0145 1.0197 1.1132 1.3953 1.1520
P 0.7310 0.1584 0.9012 0.0045 0.0356
Age β1 0.011 0.006 0.035 0.018 −0.028
OR 1.011 1.006 1.036 1.018 0.973
CL- 0.9985 0.9786 1.0055 0.9887 0.9426
CL+ 1.0245 1.0339 1.0666 1.0488 1.0038
P 0.0831 0.6755 0.0202 0.2274 0.0847
LEU β1 −4.518 −6.303 −2.310 −4.632 −6.838
OR 0.011 0.002 0.099 0.010 0.001
CL- 0.0025 0.0000 0.0049 0.0004 0.0000
CL+ 0.0477 0.0840 20.160 0.2510 0.0430
P <0.0001 0.0012 0.1327 0.0052 0.0003
PLA β1 −2.536 −5.556 −4.194 −4.392 0.947
OR 0.079 0.004 0.015 0.012 2.578
CL- 0.0150 0.0000 0.0003 0.0003 0.1099
CL+ 0.4192 0.3552 0.7826 0.5545 60.4591
P 0.0029 0.0160 0.0374 0.0236 0.5564
AL% β1 0.040 0.034 0.073 −0.090 0.262
OR 1.041 1.035 1.076 0.914 1.299
CL- 0.9828 0.9227 0.9101 0.8157 1.104
CL+ 1.1029 1.1603 1.2724 1.0245 1.529
P 0.1703 0.5592 0.3909 0.1227 0.0017
All-inclusive, additive logistic regression models to evaluate the contribution
of demographic and hematological factors to DENV incidence using different
datasets (ALL = entire data; subsets s1 to s4 ordered by day of the first
attendance at the Marilia Hemocenter; see text). AIC indicate model fit
(comparable only between subsets s1 to s4). βo = intercept, β1 = slope, OR = odds
ratio, and CL = 95 % confidence limits. Figures lower than critical P were in bold.
Considering five models (one for each dataset), critical P = 0.05/5 = 0.01. Variable
codes as in Table 1
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Fig. 2 Receiver Operating Characteristic (ROC) curves showing the individual contribution of demographic and hematological factors as
independent predictors of DENV infection, based on specificity and sensitivity. Black curves represent the entire dataset (with associated 95 %
confidence intervals), for which their partial areas under curves (AUC) are presented. Lines represent the entire dataset (with associated 95 %
confidence intervals). Subsets (see text) are s1 = squares, s2 = diamonds, s3 = triangles, s4 = circles. Variable codes as in Table 1
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statistical significant variable to be associated to DENV
diagnosis.
Currently, methods for the specific treatment and ef-
fective prevention of DENV infection are still unavail-
able. Furthermore, a specific and sensitive method for
early DENV-diagnosis is not accessible to all the regions
and patients during the course of long dengue epidemics
in developing countries, this including Brazil. In order to
improve dengue management in this situation, an alter-
native strategy used by public health care institutions in
São Paulo State is, according to the size of the popula-
tion, determine an epidemiological threshold after the
epidemic has reached the incidence rate. Before this, pa-
tients undergo dengue laboratory diagnosis. Considering
our results, if the epidemiological and hematological
profile patterns of the dengue-affected part of the popu-
lation are investigated in the beginning of the outbreak,
when specific diagnosis is carried out after the threshold
is reached, the resultant hematological profiles could be
used with more accuracy to improve disease manage-
ment. Furthermore, to reduce the number of dengue
false-positives from exclusive clinical-criteria diagnosis,
individuals notified as being infected but presenting high
scores for LEU and PLA, could be submitted to dengue
serological testing. Thus, definition of the epidemio-
logical pattern of DENV transmission in regions with re-
current outbreaks could help healthcare institutions to
prevent virus spread and manage associated diseases.
Conclusions
Herein it was shown that at the outbreak, in a middle-
sized town of São Paulo State, Brazil, the clinical criteria
applied after an epidemiological threshold has been
reached was efficient in managing both classical and
more severe cases of DF, since more than 70 % of the re-
ported cases had been confirmed by serologic detection
of the DENV NS1 antigen, associated to low leukocyte
and platelet counts. The epidemiological pattern of
DENV transmission in the town of Marilia was similar
to the American prototype, with a prevalence of DF in
the adult population and the low occurrence of
hemorrhagic forms (0.4 %). Furthermore, demographic
and hematological profiles showed a conservative tem-
poral pattern which points to the possibility of making
use of the characteristics of an outbreak detected early
in the beginning, as a means of improving management
throughout all the remaining period. Furthermore, pub-
lic healthcare institutions could be instructed on how to
inform any change in the specific pattern of the out-
break, and thus facilitate investigation of the possible
simultaneous occurrence of a new disease, as well the
opportune local entry of a different circulating DENV
genotype.
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Table 5 Paired comparison among Receiver Operating
Characteristic (ROC) curves among demographic and
hematological factors as predictors of DENV infection
Factor A Factor B AUCA AUCB D P
LEU PLA 82.41 (77.08–85.88) 79.54 (71.72–81.84) 1.88 0.0595
LEU AL% 69.51 (65.63–77.56) 3.07 0.0021
LEU AGE 57.32 (51.47–62.99) 6.77 <0.0001
LEU DAY 55.86 (51.21–62.45) 7.28 <0.0001
PLA AL% 1.45 0.1462
PLA AGE 5.52 <0.0001
PLA DAY 5.56 <0.0001
AL% AGE 3.57 0.0004
AL% DAY 3.80 0.0001
AGE DAY 0.03 0.9733
AUC is area under the curve (%) and D is the statistics related to the
difference between curves. P values lower than critical were in bold.
Considering ten contrasts, critical P = 0.05/10 = 0.005. Factors appear in
decreasing order of AUC, showed only at first time with respective 95 %
confidence limits in parenthesis. Variable codes as in Table 1
Table 6 Paired comparison among Receiver Operating
Characteristic (ROC) curves between subsets and the entire data
for demographic and hematological factors as predictors of
DENV infection
Datasets
Factor Statistics ALL s1 s2 s3 s4
Day AUC 55.86 51.61 52.49 70.24 57.95
D 0.65 0.52 −2.41 −0.32
P 0.5148 0.5970 0.0160 0.7449
Age AUC 57.32 57.60 61.57 56.47 52.19
D −0.04 −0.67 0.12 0.69
P 0.9655 0.5043 0.9040 0.4873
LEU AUC 82.41 86.82 76.26 78.97 82.25
D −1.16 1.06 0.67 0.03
P 0.2474 0.2894 0.5041 0.9726
PLA AUC 79.54 85.57 80.67 75.80 72.45
D −1.38 −0.23 0.64 1.21
P 0.1687 0.8152 0.5209 0.2269
AL% AUC 69.51 70.67 66.34 61.87 77.61
D −0.22 0.59 1.18 −1.55
P 0.8234 0.5574 0.2365 0.1222
AUC is area under the curve (%) and D is the statistics related to the difference
between curves. All P values are above the critical (critical P = 0.05/4 = 0.0125,
considering four contrasts for each factor). The only significant figure before such
correction is in bold. Variable codes as in Table 1
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